Literature DB >> 9278619

A patient with acquired immunodeficiency syndrome and untreated Encephalitozoon (Septata) intestinalis microsporidiosis leading to small bowel perforation. Response to albendazole.

J B Soule1, A L Halverson, R B Becker, M C Pistole, J M Orenstein.   

Abstract

BACKGROUND: Encephalitozoon (Septata) intestinalis is a common disseminating opportunistic intestinal microsporidian affecting patients with acquired immunodeficiency syndrome. This microsporidian does respond to albendazole therapy. A patient with acquired immunodeficiency syndrome and chronic diarrhea presented to George Washington University Hospital in January of 1996. Despite appropriate surgical specimens, no etiology had been found to explain his cholecystitis, cystitis, and enteritis 3 months previously at another hospital.
DESIGN: Tissue specimens were analyzed by light microscopy, using hematoxylin-eosin and the Armed Forces Institute of Pathology Brown-Brenn microsporidia stain, and by transmission electron microscopy. Urine and stool specimens were analyzed by modified chromotrope 2R trichrome and chitin fluorochrome stains and by transmission electron microscopy.
RESULTS: At George Washington University Hospital, disseminated E intestinalis was diagnosed from duodenal biopsy, urine, and stool specimens. On the 14th day of oral albendazole therapy, a partial small bowel resection was performed to correct a perforation (air under the diaphragm). There was no enterocyte microsporidian infection at that time, only spores undergoing macrophage digestion. Review of previous specimens showed severe E intestinalis cholecystitis, cystitis, and enteritis. Albendazole was restarted and, after 2 weeks, the patient had negative stool and urine specimens.
CONCLUSIONS: Encephalitozoon intestinalis symptomatically targets many organs, including the urinary bladder. To our knowledge, this is the first tissue-documented case of cystitis. Left untreated with albendazole, small bowel infection can lead to perforation and peritonitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278619

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  7 in total

Review 1.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Persistent damage to Enterocytozoon bieneusi, with persistent symptomatic relief, after combined furazolidone and albendazole in AIDS patients.

Authors:  D Dionisio; L I Manneschi; S Di Lollo; A Orsi; G Sterrantino; F Leoncini; M Pozzi; M A Vinattieri; A Tani; A Papucci
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

3.  Chronic Infections in Mammals Due to Microsporidia.

Authors:  Bohumil Sak; Martin Kváč
Journal:  Exp Suppl       Date:  2022

Review 4.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

5.  Microsporidium infection and perforation peritonitis: A rare association.

Authors:  Nadeem Tanveer; Sandip Barman
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jul-Dec

6.  First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target.

Authors:  Itzhel García-Torres; Ignacio De la Mora-De la Mora; Gloria Hernández-Alcántara; Dora Molina-Ortiz; Silvia Caballero-Salazar; Alfonso Olivos-García; Gabriela Nava; Gabriel López-Velázquez; Sergio Enríquez-Flores
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

Review 7.  Small intestine pathogens in AIDS: conventional and opportunistic.

Authors:  J Koch; R L Owen
Journal:  Gastrointest Endosc Clin N Am       Date:  1998-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.